Chronic opioid antagonist treatment: assessment of receptor upregulation
- 1 November 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 170 (3) , 193-200
- https://doi.org/10.1016/0014-2999(89)90539-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Evidence that μ-opioid receptors mediate midbrain “stimulation-produced analgesia” in the freely moving ratNeuroscience, 1987
- Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: Biochemical and behavioral correlatesLife Sciences, 1984
- Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the ratBrain Research, 1983
- Evaluation of the interactions of mu and delta selective ligands with [3H]D-ala2-D-Leu5-enkephalin binding to mouse brain membranesLife Sciences, 1983
- Opiate Analgesia: Evidence for Mediation by a Subpopulation of Opiate ReceptorsScience, 1980
- pA2 and receptor differentiation: A statistical analysis of competitive antagonismLife Sciences, 1979
- Chronic naloxone results in prolonged increases in opiate binding sites in brainEuropean Journal of Pharmacology, 1978
- Enhanced analgesic effects of morphine after chronic administration of naloxone in the ratEuropean Journal of Pharmacology, 1978
- Binding of 3H-naloxone in the mouse brain: Effect of ions and tolerance developmentLife Sciences, 1974
- pA, A NEW SCALE FOR THE MEASUREMENT OF DRUG ANTAGONISMBritish Journal of Pharmacology and Chemotherapy, 1947